Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01210235 · ClinicalTrials.gov registry record · NA

FLU-FIT Program at Kaiser Permanente Northern California

A NA study of Colorectal Cancer Screening, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
7,465
Enrollment target
1
Study location

NCT01210235 is a NA study of Colorectal Cancer Screening that has completed, run by University of California, San Francisco. The registered enrollment target is 7,465 participants, above the 5,490-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01210235, a NA study of Colorectal Cancer Screening, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
7,465 participants
Enrollment target
1
Study location

Study Summary

The investigators overall goal is to develop, implement, test, and disseminate an intervention to increase colorectal cancer screening rates at Kaiser Permanente (KP) by providing home fecal immunochemical test kits (FIT) to eligible patients aged 50 and older who participate in annual influenza vaccination campaigns. The investigators hypothesis is that the FLU-FIT Program will be an effective method to increase colorectal cancer screening rates at Kaiser Permanente.

Interventions

  • BEHAVIORAL FLU-FIT Program

Study Locations (1)

California

  • Kaiser Permanente Northern California - Oakland

Trial Details

FieldValue
Enrollment Target 7,465 participants
Start Date 2009-10
Est. Completion 2012-04
Phase NA

What the Registry Record Tells You About NCT01210235

The ClinicalTrials.gov registry entry for NCT01210235 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,465 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 5,490-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (36% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which FLU-FIT Program is the first listed.

NCT01210235 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01210235 about?

NCT01210235 is a clinical study titled "FLU-FIT Program at Kaiser Permanente Northern California". The investigators overall goal is to develop, implement, test, and disseminate an intervention to increase colorectal cancer screening rates at Kaiser Permanente (KP) by providing home fecal immunochemical test kits (FIT) to eligible patients aged 50 and older who participate in annual influenza vac...

What is the current status of trial NCT01210235?

This trial is currently completed. It is a NA study. The enrollment target is 7,465 participants. The study started on 2009-10. Estimated completion is 2012-04.

What conditions does trial NCT01210235 study?

This clinical trial studies the following conditions: Colorectal Cancer Screening.

What interventions are being tested in trial NCT01210235?

The interventions under investigation include: FLU-FIT Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01210235?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01210235 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.